Press Release 07 February 2022

Octopus Ventures Completes Lead Investment Into Biofidelity

Our London Technology team advised Octopus Ventures on their lead $23,000,000 Series A extension financing into Biofidelity Ltd with an investment of $10,000,000.

Octopus Ventures is one of Europe’s largest and most active venture capital firms investing in startups in the areas of health, money, deep tech, consumer and b2b software.

Biofidelity is revolutionising access to best-in-class cancer diagnostics, breaking down the barriers to better screening, monitoring and treatment for all cancer patients. 

The team was led by Ali Ramadan, Busayo Yusuff, Megan Gibson, Hayley Davis and Jack McCarthy.